Hormone Sensitivity is Reflected in the Phospholipid Profiles of Breast Cancer Cell Lines Marina SterinJack S. CohenIsrael Ringel OriginalPaper Pages: 1 - 11
Translational research and the changing face of breast cancer Mitch Dowsett OriginalPaper Pages: 1 - 2
Elevated Expression of the Tumor Suppressing Protein p53 is Associated with the Presence of Mouse Mammary Tumor-Like env Gene Sequences (MMTV-like) in Human Breast Cancer James S. LawsonDinh D. TranWilliam D. Rawlinson OriginalPaper Pages: 13 - 17
Estrogen and progesterone receptor isoforms: clinical significance in breast cancer Suzanne AW FuquaYukun Cui OriginalPaper Pages: 3 - 10
Genetic Variants of the Sulfotransferase 1A1 and Breast Cancer Risk Uwe LangsenlehnerPeter KripplHellmut Samonigg OriginalPaper Pages: 19 - 22
Biomarker investigations from the ATAC trial: the role of TA01 Mitch Dowsett OriginalPaper Pages: 11 - 18
Mutations of the p53 Gene and Loss of Heterozygosity at Chromosome 17p13.1 are Associated with Increased Survivin Expression in Breast Cancer Naoki TsujiKaori FuruseNaoki Watanabe OriginalPaper Pages: 23 - 31
Overexpression of Bcl-xL in Human Breast Cancer Cells Enhances Organ-Selective Lymph Node Metastasis Laura EspañaYolanda FernándezAngels Sierra OriginalPaper Pages: 33 - 44
Quality of Life of Breast Cancer Survivors After a Recurrence: A Follow-Up Study Sindy OhLara HeflinPatricia A. Ganz OriginalPaper Pages: 45 - 57
Failure of High Risk Women to Produce Nipple Aspirate Fluid Does Not Exclude Detection of Cytologic Atypia in Random Periareolar Fine Needle Aspiration Specimens Priyanka SharmaJennifer R. KlempCarol J. Fabian OriginalPaper Pages: 59 - 64
Comparative Analysis Between the HER2 Status in Primary Breast Cancer Tissue and the Detection of Isolated Tumor Cells in the Bone Marrow C. SchindlbeckW. JanniK. Friese OriginalPaper Pages: 65 - 74
Does Subjective Burden of Early Breast Cancer and its Treatment Affect Immune Measures During Adjuvant Therapy? Marzio E.E. SabbioniJürg BernhardChristoph Hürny OriginalPaper Pages: 75 - 86
EGFR and EGFRvIII Expression in Primary Breast Cancer and Cell Lines James M. RaeJoshua O. ScheysMarc E. Lippman OriginalPaper Pages: 87 - 95
The Experimental Antitumor Agents Phortress and Doxorubicin are Equiactive Against Human-Derived Breast Carcinoma Xenograft Models Iduna FichtnerAnne MonksTracey D. Bradshaw OriginalPaper Pages: 97 - 107
Possible Association Between c-erbB-2 and Human Papillomavirus-16 in Breast Cancer Patients Ozden AltundagKadri AltundagMehmet Gunduz OriginalPaper Pages: 109 - 109
